Zoetis said Heidi C. Chen will cease her role as Executive Vice President, General Counsel and Corporate Secretary, and Business Lead of Human Health Diagnostics, effective April 16, 2024.

1. 01

   Zoetis said Heidi C. Chen will cease her role as Executive Vice President, General Counsel and Corporate Secretary, and Business Lead of Human Health Diagnostics, effective April 16, 2024.

2. 02

   The company said Ms. Chen will continue as an employee advisor through July 16, 2024, after which it expects she will serve as a non-employee consultant.

3. 03

   Zoetis said Roxanne Lagano will serve as interim General Counsel and Corporate Secretary while the company searches for Ms. Chen's permanent replacement. It said it is currently working to identify external and internal candidates.

4. 04

   Zoetis said Ms. Chen is eligible for separation benefits under Section 3.1 of the Executive Severance Plan and is also retirement-eligible, so she may receive certain other benefits available to retirement-eligible employees.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.